Skip to content

Case reports of severe dolutegravir-related depression

What is “successful ageing” for people living with HIV?

Liver fibrosis speeds up around the menopause in women with HIV and HCV co-infection

People with HIV are at risk for liver fibrosis and steatosis

Peripheral artery disease more common in people with HIV with lower CD4 counts

Incidence of anal cancer has already peaked among HIV-positive gay men; reductions can be achieved with expanded ART coverage and screening

Switch from boosted protease inhibitor to dolutegravir reduces lipids in people with HIV at higher risk of heart disease

Why curing HIV may be like curing cancer – and may be as difficult

Monsef Benkirane at the HIV Cure and Cancer Forum, IAS 2017. Photo by Marcus Rose/IAS

Can we achieve a complete HIV cure in more patients?

Michael Louella at the HIV Cure and Cancer Forum, IAS 2017. Photo by Marcus Rose/IAS